Shelley B Thunen Rx Sight, Inc. (RXST) insider trading activity

Shelley B Thunen is Chief Financial Officer of RxSight, Inc.. Currently has a direct ownership of 13,938 shares of RXST, which is worth approximately $814,954. The most recent transaction as insider was on May 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $52.86 per share, resulting in proceeds of $528,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.9K

1.8% 3M change

n/a 12M change

Total Value Held $814,954

Shelley B Thunen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Open market or private sale	$528,600 $52.86 p/Share	10,000 Reduced 41.77%	13,938 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$159,853 $15.6 p/Share	10,247 Added 29.98%	23,938 Common Stock
Mar 01 2024	SELL Open market or private sale	$561,200 $56.12 p/Share	10,000 Reduced 42.21%	13,691 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$156,000 $15.6 p/Share	10,000 Added 29.68%	23,691 Common Stock
Feb 06 2024	SELL Open market or private sale	$753,586 $47.47 p/Share	15,875 Reduced 53.69%	13,691 Common Stock
Feb 06 2024	BUY Exercise of conversion of derivative security	$237,331 $14.95 p/Share	15,875 Added 34.94%	29,566 Common Stock
Feb 05 2024	SELL Open market or private sale	$429,057 $47.02 p/Share	9,125 Reduced 39.99%	13,691 Common Stock

Feb 05 2024	BUY Exercise of conversion of derivative security	$154,641 $9.65 p/Share	16,025 Added 41.26%	22,816 Common Stock
Jan 26 2024	SELL Open market or private sale	$1,496,778 $47.11 p/Share	31,772 Reduced 82.39%	6,791 Common Stock
Jan 26 2024	BUY Exercise of conversion of derivative security	$352,201 $9.71 p/Share	36,272 Added 48.47%	38,563 Common Stock
Jan 02 2024	SELL Open market or private sale	$392,000 $39.2 p/Share	10,000 Reduced 81.36%	2,291 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$156,000 $15.6 p/Share	10,000 Added 44.86%	12,291 Common Stock
Dec 15 2023	SELL Open market or private sale	$787,000 $39.35 p/Share	20,000 Reduced 89.72%	2,291 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$312,000 $15.6 p/Share	20,000 Added 47.29%	22,291 Common Stock

Also insider at

PMGM

Priveterra Acquisition Corp. Financial Services

Director

GRPH

Graphite Bio, Inc. Healthcare

Director

SBT

Shelley B Thunen

Chief Financial Officer

Aliso Viejo, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXST shares.

Notify only if

Value

Insider Trading

Get notified when an Rx Sight, Inc. insider buys or sells RXST shares.

Notify only if

Operation

Value

Type

News

Receive news related to RxSight, Inc.

Track Activities on RXST

Account